Status:

RECRUITING

Healthy HeaAring for Healthy Ageing: Data-driven Hearing Rehabilitation Intervention to Promote Healthy Hearing

Lead Sponsor:

Kuopio University Hospital

Collaborating Sponsors:

University of Eastern Finland

Conditions:

Sensorineural Hearing Loss

Cognitive Decline

Eligibility:

All Genders

65-84 years

Phase:

NA

Brief Summary

The goal of the HAHA trial is to prove that the treatment of HI and prevention of HI-related cognitive decline are most likely to be effective if HI is approached as a broader neurodegenerative entity...

Detailed Description

Hearing impairment (HI) is a major public health problem. HI has also been identified as a significant potentially modifiable risk factor for dementia. Thus, hearing rehabilitation may contribute to d...

Eligibility Criteria

Inclusion

  • Mild to moderately severe sensorineural HI (PTA (0,5-4kHz) between 20-64 dB (HL), as per Global Burden of Disease Expert Group on Hearing loss criteria)
  • Community-dwelling, i.e. living at home / not living in a care home or nursing home
  • Proficiency in Finnish language
  • First-time hearing aid user

Exclusion

  • Conductive hearing loss (air-bone gap more than 20 dB HL in two consecutive frequencies)
  • Difference between hearing levels of the ears is more than 15dB (HL) in three consecutive frequencies
  • Hearing aid contraindication
  • Previously diagnosed dementia, or current use of cholinesterase inhibitors and/or memantine. If there is a current ongoing diagnostic process for suspected dementia, the decision on eligibility will be made by an experienced study physician based on medical records and clinical judgement.
  • Any health conditions severely impairing vision, mobility, communication, and/or ability to participate in study visits and complete study assessments, as judged by the study nurse and/or physician.

Key Trial Info

Start Date :

October 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 30 2027

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT06495268

Start Date

October 1 2024

End Date

October 30 2027

Last Update

November 22 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kuopio University Hospital

Kuopio, Finland, 70210